Sponsored ADR (1 ADS : 1 Ordinary) International Reporting
OTC Pink Current Information
Contact Info
  • Level 5
  • 160 Queen Street
  • Melbourne, VIC 3000
  • Australia

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
CIK 0001290877
Fiscal Year End 6/30
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: Australia
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Philippe Wolgen CEO
Darren Keamy CFO
Colin Mackie Director, Bus. Dev.
Company Directors
Philippe Wolgen
Company Notes
  • Formerly=EpiTan Ltd. until 3-06
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
CLVLY Security Details Other Company Securities
Share Structure
Market Value1 $151,908,550 a/o Aug 18, 2017
Authorized Shares Not Available
Outstanding Shares 30,381,710 a/o Dec 31, 2010
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
BNY Mellon
Shareholders of Record Not Available
Non US Stock Exchange Listing
CUV - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 7,435 (-7.99%)
Jul 14, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security